Michael Roost Clausen

Ph.d.-studerende, Forsker

Profile photoMichael Roost Clausen
Ph.d.-studerende, Forsker
Institut for Klinisk Medicin - Hæmatologisk afdeling R, THG
Institut for Klinisk Medicin - Hæmatologisk afdeling R, THG
Postaddresse:
Tage-Hansens Gade 2
8000
Aarhus C
Danmark
E-mail: mrc@clin.au.dk

Ansættelse

Publikationer

Depth of neutrophil nadir after first cycle of R-CHOP predicts outcome in diffuse large B-cell lymphoma - a nationwide population-based cohort study

Clausen, M. R., Ulrichsen, S. P., Larsen, T. S., Poulsen, C. B., Tojaga, S., Pedersen, P. T., Madsen, J., Pedersen, R. S., Josefsson, P. L., Gørløv, J. S., Nørgaard, M. & d'Amore, F., aug. 2019, I : Leukemia and Lymphoma. 60, 8, s. 1950-1957 8 s.

No differential overall or relative survival effect of rituximab in male and female patients with diffuse large B-cell lymphoma: a Danish population-based study of 3783 patients

Jakobsen, L. H., Biccler, J. L., Brown, P. D. N., Jørgensen, J. M., Josefsson, P. L., Poulsen, C. B., Starklint, J., Clausen, M. R., Pedersen, P. T., Juul, M. B., Severinsen, M. T., Bøgsted, M. & El-Galaly, T. C., 1 jan. 2019, I : Leukemia and Lymphoma.

Intravenous but not intrathecal central nervous system–directed chemotherapy improves survival in patients with testicular diffuse large B-cell lymphoma

Mannisto, S., Vähämurto, P., Pollari, M., Clausen, M. R., Jyrkkiö, S., Kellokumpu-Lehtinen, P. L., Kovanen, P., Karjalainen-Lindsberg, M. L., d'Amore, F. & Leppä, S., 2019, I : European Journal of Cancer. 115, s. 27-36 10 s.

The incidence of bleomycin induced lung toxicity is increased in Hodgkin lymphoma patients over 45 years exposed to granulocyte-colony stimulating growth factor

Andersen, M. D., Kamper, P., d’Amore, A., Clausen, M., Bentzen, H. & d'Amore, F., okt. 2018, I : Leukemia and Lymphoma.

Treatment strategies and outcomes in diffuse large B-cell lymphoma among 1011 patients aged 75 years or older: A Danish population-based cohort study

Juul, M. B., Jensen, P. H., Engberg, H., Wehberg, S., Dessau-Arp, A., Haziri, D., Kristensen, H. B., Baech, J., Schurmann, L., Clausen, M. R., Valentin, R., Knudsen, L. M., Munksgaard, L., El-Galaly, T. C., Frederiksen, H. & Larsen, T. S., aug. 2018, I : European Journal of Cancer. 99, s. 86-96 11 s.

Up-front rituximab maintenance improves outcome in patients with follicular lymphoma: a collaborative Nordic study

Madsen, C., Clausen, M. R., Plesner, T. L., Pasanen, A., Kuismanen, T., Bentzen, H. H., Jørgensen, J. M., Sillesen, I. B., Himmelstrup, B. M., Rønnov-Jessen, D., Jensen, K. R., Pettinger, A. M., Ludvigsen, M., Leppä, S. & d'Amore, F. A., 10 jul. 2018, I : Blood Advances. 2, 13, s. 1562-1571 10 s.

Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma

El-Galaly, T. C., Cheah, C. Y., Bendtsen, M. D., Nowakowski, G. S., Kansara, R., Savage, K. J., Connors, J. M., Sehn, L. H., Goldschmidt, N., Shaulov, A., Farooq, U., Link, B. K., Ferreri, A. J. M., Calimeri, T., Cecchetti, C., Dann, E. J., Thompson, C. A., Inbar, T., Maurer, M. J., Gade, I. L., Juul, M. B., Hansen, J. W., Holmberg, S., Larsen, T. S., Cordua, S., Mikhaeel, N. G., Hutchings, M., Seymour, J. F., Clausen, M. R., Smith, D., Opat, S., Gilbertson, M., Thanarajasingam, G. & Villa, D., apr. 2018, I : European Journal of Cancer. 93, s. 57-68 12 s.

The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma: An international multicenter study of 1532 patients treated with chemoimmunotherapy

El-Galaly, T. C., Villa, D., Michaelsen, T. Y., Hutchings, M., Mikhaeel, N. G., Savage, K. J., Sehn, L. H., Barrington, S., Hansen, J. W., Smith, D., Rady, K., Juul Mylam, K., Larsen, T. S., Holmberg, S., Juul, M. B., Cordua, S., Clausen, M. R., Jensen, K. B., Johnsen, H. E., Seymour, J. F., Connors, J. M., de Nully Brown, P., Bøgsted, M. & Cheah, C. Y., apr. 2017, I : European journal of cancer (Oxford, England : 1990). 75, s. 195-203 9 s.

Uterine, but not ovarian, female reproductive organ involvement at presentation by diffuse large B-cell lymphoma is associated with poor outcomes and a high frequency of secondary CNS involvement

El-Galaly, T. C., Cheah, C. Y., Hutchings, M., Mikhaeel, N. G., Savage, K. J., Sehn, L. H., Barrington, S., Hansen, J. W., Poulsen, M. Ø., Smith, D., Rady, K., Mylam, K. J., Larsen, T. S., Holmberg, S., Juul, M. B., Cordua, S., Clausen, M. R., Jensen, K. B., Bøgsted, M., Johnsen, H. E., Seymour, J. F., Connors, J. M., Brown, P. D. N. & Villa, D., dec. 2016, I : British Journal of Haematology. 175, 5, s. 876-883 8 s.

An International Collaborative Study of Outcome and Prognostic Factors in Patients with Secondary CNS Involvement By Diffuse Large B-Cell Lymphoma

El-Galaly, T. C., Cheah, C. Y., Bendtsen, M. D., Thanarasjasingam, G., Kansara, R., Savage, K. J., Connors, J. M., Goldschmidt, N., Shaulov, A., Farooq, U., Sehn, L. H., Dann, E. J., Thompson, C. A., Inbar, T., Link, B. K., Maurer, M. J., Gade, I. L., Juul, M. B., Hansen, J. W., Holmberg, S., Larsen, T. S., Opat, S., Mikhaeel, N. G., Seymour, J. F., Clausen, M. R., Smith, D., Gilbertson, M., Nowakowski, G. S., Cordua, S., Hutchings, M. & Villa, D., 9 nov. 2016, I : Blood. 128, 22, s. 1874-1874 1 s.

The Combination of Pixantrone, Etoposide, Bendamustine and, in CD20+ Tumors, Rituximab (PREBEN) Shows Promising Feasibility/Efficacy in Heavily Pre-Treated Aggressive Lymphomas of B- and T-Cell Phenotype - Results of the Pre-Trial Experience Leading to a Nordic Phase 1/2 Study (the PREBEN Trial)

Clausen, M. R., Leppa, S., Brown, P. D. N., Goerloev, J. S., Panny, M., Willenbacher, W., Sillesen, I. B., Segel, E., Bentzen, H. H. N., Thorsgaard, M., Pulczynski, E. J., Kamper, P., Gormsen, L. C., Mortensen, J., Lauritzsen, G., Relander, T. & d'Amore, F., 9 nov. 2016, I : Blood. 128, 22, s. 1782-1782 1 s.

The Danish National Lymphoma Registry: Coverage and Data Quality

Arboe, B., El-Galaly, T. C., Clausen, M. R., Munksgaard, P. S., Stoltenberg, D., Nygaard, M. K., Klausen, T. W., Christensen, J. H., Gørløv, J. S. & Brown, P. D. N., 23 jun. 2016, I : PLOS ONE. 11, 6, s. e0157999 12 s.

Upfront Rituximab Maintenance after Induction Therapy Improves Outcome and Reduces the Risk of Histological Transformation in Patients with Follicular Lymphoma – Real World Data form a Danish Population-Based Cohort

Madsen, C., Clausen, M. R., Ludvigsen, M., Plesner, T. L. & D'Amore, F. A., 2016.

Tumour-associated mast cells in classical Hodgkin's lymphoma: correlation with histological subtype, other tumour-infiltrating inflammatory cell subsets and outcome

Andersen, M. D., Nielsen, P. S., Bendix, K., Riber-Hansen, R., Steiniche, T., Hamilton-Dutoit, S., Clausen, M. & d'Amore, F., 11 maj 2015, I : European Journal of Haematology. s. 252-259 7 s.

Role of routine imaging in detecting recurrent lymphoma; a review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma

El-Galaly, T. C., Mylam, K. J., Bøgsted, M., Brown, P. D. N., Rossing, M., Gang, A. O., Haglund, A., Arboe, B., Clausen, M. R., Jensen, P., Pedersen, M., Bukh, A., Jensen, B. A., Poulsen, C. B., d'Amore, F. & Hutchings, M., 3 feb. 2014, I : American Journal of Hematology. 89, 6, s. 575-580

Preliminary clinical experience on the efficacy and feasibility of a new combination regimen consisting of pixantrone, etoposide and bendamustine with or without the addition of rituximab in patients with relapsed/refractory aggressive non-hodgkin lymphomas

D'Amore, F. A., Jørgensen, J. M., Sillesen, I. B., Segel, E., Bentzen, H. H. N., Thorsgaard, M., Pulcynski, E., Pedersen, B., Gillstrom, D., Clausen, M. R., Kamper, P., Silkjær, T., Gormsen, L. C., Leppä, S. & Toldbod, H., 2014, I : Blood. 124, 21

Very long-term remission induced by short-term rituximab monotherapy in a patient with heavily pretreated, chronic immune thrombocytopenic purpura

Clausen, M. R., Segel, E. K., Brandsborg, M. & d'Amore, F., mar. 2011, I : European Journal of Haematology. 86, 3, s. 256-9 4 s.

Aleutian mink disease virus and humans

Jepsen, J. R., d'Amore, F., Baandrup, U., Clausen, M. R., Gottschalck, E. & Aasted, B., dec. 2009, I : Emerging Infectious Diseases (Print Edition). 15, 12, s. 2040-2 3 s.

Aktiviteter

23rd Congress of the European Hematology Association

Michael Roost Clausen (Deltager)
14 jun. 201817 jun. 2018

59th ASH Annual Meeting & Exposition

Michael Roost Clausen (Deltager)
9 dec. 201712 dec. 2017

Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA.

Michael Roost Clausen (Gæsteforsker)
11 nov. 201713 dec. 2017

14th ICML

Michael Roost Clausen (Deltager)
14 jun. 2017

2nd nordic meeting on tumor microenvironment and lymphoma

Michael Roost Clausen (Deltager)
18 maj 2017

58th ASH Annual Meeting & Exposition

Michael Roost Clausen (Deltager)
3 dec. 20166 dec. 2016

Nordic Lymphoma Group Plenary Meeting

Michael Roost Clausen (Deltager)
7 nov. 2016

1st nordic meeting on tumor microenvironment and lymphoma

Michael Roost Clausen (Deltager)
19 maj 2016

11th International Conference on Malignant Lymphoma ICML

Michael Roost Clausen (Deltager)
jun. 2011

Projekter

Outcome Determinants in Diffuse Large B-cell Lymphoma.

Clausen, M. R.

01/05/201530/04/2018